Microbial keratitis in Waikato, New Zealand

被引:41
作者
Pandita, Archana [1 ]
Murphy, Christopher [1 ]
机构
[1] Waikato Publ Hosp, Dept Ophthalmol, Hamilton, New Zealand
关键词
antimicrobial; corneal scrape; initial treatment; keratitis; monotherapy; BACTERIAL CORNEAL ULCERS; PREDISPOSING FACTORS; EMERGING RESISTANCE; CIPROFLOXACIN; FLUOROQUINOLONE; TRENDS; CEFAZOLIN; AUSTRALIA; THERAPY;
D O I
10.1111/j.1442-9071.2010.02480.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Bacterial keratitis is a potentially sight-threatening condition. This study is performed to identify the common causative organisms for bacterial keratitis in Waikato region and the antibiotic sensitivities to these organisms. Design: Retrospective, observational, case series. Participants: The microbiology records of all patients with bacterial keratitis who presented to the Ophthalmology department, Waikato Hospital, New Zealand between January 2003 and December 2007. Methods: The corneal scrape results were reviewed. Antibiotic sensitivity for the organism was tested following National Committee for Clinical Laboratory Standards (NCCLS) method. Main Outcome Measures: In vitro laboratory susceptibility testing of ocular isolates to various antibiotics. Results: A total of 265 scrapes were performed. Gram stain was positive in 35 (13.2%) eyes. Positive culture was seen in 174 (65.6%) scrapes; 78.2% were Gram-positive and 20.2% were Gram-negative organisms. Most common Gram-positive organisms were coagulase-negative Staphylococci (40.8%) and Staphylococcus aureus (11.5%). Most common Gram-negative organisms were Moraxalla species (8.0%) and Pseudomonas aeroginosa (3.4%). Of the bacterial organisms 99% were sensitive to ciprofloxacin. All Gram-negative organisms and 95.5% Gram-positive organisms were sensitive to tobramycin; 96.6% Gram-positive organisms and 98.3% Gram-negative organisms were sensitive to cefuroxime. Conclusions: Our results are comparable to other regions in New Zealand but the incidence of coagulase-negative Staphylococcus is much higher in this region compared with other New Zealand studies. It seems appropriate to start patients with corneal ulcers initially on fluoroquinolone mono-therapy while awaiting culture results.
引用
收藏
页码:393 / 397
页数:5
相关论文
共 23 条
[1]   Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis [J].
Afshari, Natalie A. ;
Ma, Joseph J. K. ;
Duncan, Scott M. ;
Pineda, Roberto ;
Starr, Christopher E. ;
Decroos, Francis Char ;
Johnson, Carl S. ;
Adelman, Ron A. .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, 24 (02) :217-223
[2]   Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones [J].
Alexandrakis, G ;
Alfonso, EC ;
Miller, D .
OPHTHALMOLOGY, 2000, 107 (08) :1497-1502
[3]   Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases [J].
Bourcier, T ;
Thomas, F ;
Borderie, V ;
Chaumeil, C ;
Laroche, L .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (07) :834-838
[4]   Risk factors for microbial keratitis with contemporary contact lenses - A case-control study [J].
Dart, J. K. G. ;
Radford, C. F. ;
Minassian, D. ;
Verma, S. ;
Stapleton, F. .
OPHTHALMOLOGY, 2008, 115 (10) :1647-1654
[5]   Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers [J].
Gangopadhyay, N ;
Daniell, M ;
Weih, L ;
Taylor, HR .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (04) :378-384
[6]   Severe microbial keratitis in temperate and tropical Western Australia [J].
Gebauer, A ;
McGhee, CNJ ;
Crawford, GJ .
EYE, 1996, 10 :575-580
[7]   Emerging fluoroquinolone resistance in bacterial keratitis - A 5-year review [J].
Goldstein, MH ;
Kowalski, RP ;
Gordon, YJ .
OPHTHALMOLOGY, 1999, 106 (07) :1313-1318
[8]   Bacterial keratitis in Christchurch, New Zealand, 1997-2001 [J].
Hall, RC ;
McKellar, MJ .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (05) :478-481
[9]   Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers [J].
Hyndiuk, RA ;
Eiferman, RA ;
Caldwell, DR ;
Rosenwasser, GO ;
Santos, CI ;
Katz, HR ;
Badrinath, SS ;
Reddy, MK ;
Adenis, JP ;
Klauss, V ;
COhen, E ;
MarechalCourtois, C ;
Murta, J ;
Darrell, RW ;
Denis, P ;
Heidemann, DH ;
Insler, MS ;
John, T ;
Klauss, V ;
Lass, JH ;
Limberg, MB ;
McCulley, JP ;
Rosenwasser, GOD ;
Rowsey, JJ ;
Santos, C ;
Sher, N ;
Ullman, S ;
Verin, P ;
Wilhelmus, KR ;
Wills, R ;
Wolf, TC .
OPHTHALMOLOGY, 1996, 103 (11) :1854-1862
[10]  
JONES RN, 1996, AM J MED S6A, V100, P3